An International Randomized Study to Compare SPIES Versus WLI
NCT02252549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700
Last updated 2021-07-28
Summary
This study is a multicenter randomized controlled trial in which the efficacy between SPIES assisted and WLI assisted TURB are compared. Subjects in the experimental arm (Arm A) will undergo SPIES assisted TURB, whereas subjects in the control arm (Arm B) will receive treatment with WLI assisted TURB only. Baseline characteristics will be recorded, as well as short and long-term follow up.
Conditions
Interventions
- DEVICE
-
SPIES+WLI assisted TURB
- DEVICE
-
WLI assisted TURB
Sponsors & Collaborators
-
Clinical Research Office of the Endourological Society
lead OTHER
Principal Investigators
-
Jean de la Rosette · Clinical Research Office of the Endourological Society
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2020-04-30
- Completion
- 2021-07-31
More Related Trials
-
Clinical Performance Evaluation of the C2i Test
NCT05860543 ·Status: WITHDRAWN
-
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
NCT02298998 ·Status: COMPLETED
-
Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer
NCT01180478 ·Status: COMPLETED ·Phase: NA
-
A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)
NCT01799499 ·Status: WITHDRAWN ·Phase: NA
-
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
NCT07029256 ·Status: RECRUITING
-
Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
NCT01803295 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer
NCT06829823 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
NCT02560584 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT04688931 ·Status: TERMINATED ·Phase: PHASE3
-
Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer
NCT01827943 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
NCT07087860 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
NCT06971614 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
NCT06111235 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer
NCT05445648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment
NCT07201675 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer
NCT06255964 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
NCT02311101 ·Status: COMPLETED ·Phase: PHASE1
-
Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder
NCT03529890 ·Status: UNKNOWN ·Phase: PHASE2
-
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
NCT03266900 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Surgery and BCG in Treating Patients With Bladder Cancer
NCT00002990 ·Status: COMPLETED ·Phase: PHASE3
-
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
NCT06324058 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial
NCT07257718 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
High Resolution Imaging for Early and Better Detection of Bladder Cancer
NCT02340650 ·Status: COMPLETED
-
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT02844816 ·Status: COMPLETED ·Phase: PHASE2
-
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NCT07180212 ·Status: RECRUITING ·Phase: NA